scholarly journals The use of ranolazine in the treatment of coronary heart disease

2014 ◽  
Vol 5 (3-4) ◽  
pp. 48-53
Author(s):  
V. S Zadionchenko ◽  
G. G Shehyan ◽  
A. A Yalymov ◽  
S. I Varentsov

The paper presents the study of a new anti-anginal drug - sodium channel inhibitor ranolazine. Considered antianginal, anti-ischemic effect of the drug. Described reduction in angina attacks, increased exercise tolerance and quality of life of patients with stable angina during treatment with ranolazine. Discusses indications, contraindications, side effects, as well as the major clinical trials of the drug ranolazine in patients with coronary heart disease.

PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0152030 ◽  
Author(s):  
Jelena Stevanović ◽  
Petros Pechlivanoglou ◽  
Marthe A. Kampinga ◽  
Paul F. M. Krabbe ◽  
Maarten J. Postma

2012 ◽  
Vol 21 (10) ◽  
pp. 1863-1871 ◽  
Author(s):  
Barbora Silarova ◽  
Iveta Nagyova ◽  
Jaroslav Rosenberger ◽  
Martin Studencan ◽  
Daniela Ondusova ◽  
...  

2008 ◽  
Vol 8 (4) ◽  
pp. 707-710 ◽  
Author(s):  
Seyedeh-Monavar Yazdi ◽  
Simin Hosseinian ◽  
Mansoure Eslami ◽  
Ali Fathi-Asht

Sign in / Sign up

Export Citation Format

Share Document